article thumbnail

An Additional Physician from Leading Sarasota Cardiology Practice to Now Offer the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Concierge Choice Physicians

The CCP Hybrid Choice program is unique in that it offers patients the choice to join, or to remain in the traditional practice, as before. The CCP Hybrid Choice program is unique in that it offers patients the choice to join, or to remain in the traditional practice, as before. The patient decides what’s right for them.

article thumbnail

Green Practice News: April 2025

My Green Doctor

In This Issue : New Research: Teaching Patients about Climate Resilience Make the Pledge Today to Go Green Get Ready for Earth Day 2025 (part 2)! from 2000 to 2018 among people over 65 years old. Patients rely on medical professionals for guidance on how lifestyle choices impact long-term health. Contact us today! of total U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Second Circuit Agrees that Copay Assistance Programs May Violate the Anti-Kickback Statute

FDA Law Blog

Recognizing that this out-of-pocket cost still represents a significant financial barrier for many patients, Pfizer proposed a Direct Copay Assistance Program for Medicare Part D beneficiaries using tafamidis. Under Medicare’s pricing formula, beneficiaries who take tafamidis are responsible for a copay of approximately $13,000 per year.

article thumbnail

DOJ Re-Brands Guidance Documents

FDA Law Blog

The federal government does its own version of rebranding with each change in administration. This policy, announced by then Associate Attorney General Rachel Brand in 2018 was referred to as the Brand Memo. clinical testing of implanted brain computer interface devices for patients with paralysis or amputation), enforcement (e.g.,

article thumbnail

FDA Publishes Discussion Paper Seeking Feedback on 3D Printing of Medical Devices at the Point of Care

FDA Law Blog

In May 2016, FDA released a draft guidance document titled “Technical Considerations for Additive Manufactured Devices” (see our blog post on the draft guidance here ), which was finalized in 2018 (see our blog post on the final guidance here ). Specifically, that it allows for fast production of “patient-matched devices” (i.e.,

Medical 98
article thumbnail

Approaches for Quelling Stigma related to COVID-19

BMJ

Many Chinese expressed their disapproval of the many untrusted sources of information online while demonstrating a high level of trust towards the central government. How to reduce the negative psychological impact MRSA isolation on patients. Shaanxi, Xi’an, China: Shaanxi Normal University; 2018. Nurs Times 2010;106(36):14–16.

article thumbnail

The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation

FDA Law Blog

Manufacturers may choose not to participate in this program, but the federal government will not reimburse for their outpatient drugs under Medicaid or Medicare Part B if they do not. A 2018 report by the Government Accountability Office (“GAO”) found similar issues, as well as contract pharmacy noncompliance and poor federal oversight.